Copyright Reports & Markets. All rights reserved.

Global Biopharmaceutical Contract Manufacturing Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Growth Factors
    • 1.4.3 Interferons
    • 1.4.4 Monoclonal Antibodies
    • 1.4.5 Recombinant Hormones
    • 1.4.6 Vaccines
    • 1.4.7 Insulin
    • 1.4.8 Others
  • 1.5 Market by Application
    • 1.5.1 Global Biopharmaceutical Contract Manufacturing Market Share by Application: 2020 VS 2026
    • 1.5.2 Autoimmune Diseases
    • 1.5.3 Oncology
    • 1.5.4 Metabolic Diseases
    • 1.5.5 Ophthalmology
    • 1.5.6 Cardiovascular Diseases
    • 1.5.7 Infectious Diseases
    • 1.5.8 Neurology
    • 1.5.9 Respiratory Disorders
    • 1.5.10 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Biopharmaceutical Contract Manufacturing Market Perspective (2015-2026)
  • 2.2 Global Biopharmaceutical Contract Manufacturing Growth Trends by Regions
    • 2.2.1 Biopharmaceutical Contract Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Biopharmaceutical Contract Manufacturing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Biopharmaceutical Contract Manufacturing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Biopharmaceutical Contract Manufacturing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Biopharmaceutical Contract Manufacturing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Biopharmaceutical Contract Manufacturing Players by Market Size
    • 3.1.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue (2015-2020)
    • 3.1.2 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Biopharmaceutical Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio
    • 3.2.1 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing Revenue in 2019
  • 3.3 Biopharmaceutical Contract Manufacturing Key Players Head office and Area Served
  • 3.4 Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
  • 3.5 Date of Enter into Biopharmaceutical Contract Manufacturing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Type (2015-2020)
  • 4.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)
  • 5.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
  • 6.2 Biopharmaceutical Contract Manufacturing Key Players in North America (2019-2020)
  • 6.3 North America Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
  • 6.4 North America Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
  • 7.2 Biopharmaceutical Contract Manufacturing Key Players in Europe (2019-2020)
  • 7.3 Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
  • 7.4 Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

8 China

  • 8.1 China Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
  • 8.2 Biopharmaceutical Contract Manufacturing Key Players in China (2019-2020)
  • 8.3 China Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
  • 8.4 China Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
  • 9.2 Biopharmaceutical Contract Manufacturing Key Players in Japan (2019-2020)
  • 9.3 Japan Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
  • 9.4 Japan Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
  • 10.2 Biopharmaceutical Contract Manufacturing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

11 India

  • 11.1 India Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
  • 11.2 Biopharmaceutical Contract Manufacturing Key Players in India (2019-2020)
  • 11.3 India Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
  • 11.4 India Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
  • 12.2 Biopharmaceutical Contract Manufacturing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
  • 12.4 Central & South America Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Lonza Group
    • 13.1.1 Lonza Group Company Details
    • 13.1.2 Lonza Group Business Overview
    • 13.1.3 Lonza Group Biopharmaceutical Contract Manufacturing Introduction
    • 13.1.4 Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020))
    • 13.1.5 Lonza Group Recent Development
  • 13.2 Baxter Biopharma Solutions
    • 13.2.1 Baxter Biopharma Solutions Company Details
    • 13.2.2 Baxter Biopharma Solutions Business Overview
    • 13.2.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Introduction
    • 13.2.4 Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
    • 13.2.5 Baxter Biopharma Solutions Recent Development
  • 13.3 Samsung
    • 13.3.1 Samsung Company Details
    • 13.3.2 Samsung Business Overview
    • 13.3.3 Samsung Biopharmaceutical Contract Manufacturing Introduction
    • 13.3.4 Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
    • 13.3.5 Samsung Recent Development
  • 13.4 Fujifilm Diosynth Biotechnologies
    • 13.4.1 Fujifilm Diosynth Biotechnologies Company Details
    • 13.4.2 Fujifilm Diosynth Biotechnologies Business Overview
    • 13.4.3 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Introduction
    • 13.4.4 Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
    • 13.4.5 Fujifilm Diosynth Biotechnologies Recent Development
  • 13.5 Boehringer Ingelheim
    • 13.5.1 Boehringer Ingelheim Company Details
    • 13.5.2 Boehringer Ingelheim Business Overview
    • 13.5.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Introduction
    • 13.5.4 Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
    • 13.5.5 Boehringer Ingelheim Recent Development
  • 13.6 Patheon
    • 13.6.1 Patheon Company Details
    • 13.6.2 Patheon Business Overview
    • 13.6.3 Patheon Biopharmaceutical Contract Manufacturing Introduction
    • 13.6.4 Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
    • 13.6.5 Patheon Recent Development
  • 13.7 Rentschler Biotechnologie
    • 13.7.1 Rentschler Biotechnologie Company Details
    • 13.7.2 Rentschler Biotechnologie Business Overview
    • 13.7.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Introduction
    • 13.7.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
    • 13.7.5 Rentschler Biotechnologie Recent Development
  • 13.8 Biomeva
    • 13.8.1 Biomeva Company Details
    • 13.8.2 Biomeva Business Overview
    • 13.8.3 Biomeva Biopharmaceutical Contract Manufacturing Introduction
    • 13.8.4 Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
    • 13.8.5 Biomeva Recent Development
  • 13.9 Probiogen
    • 13.9.1 Probiogen Company Details
    • 13.9.2 Probiogen Business Overview
    • 13.9.3 Probiogen Biopharmaceutical Contract Manufacturing Introduction
    • 13.9.4 Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
    • 13.9.5 Probiogen Recent Development
  • 13.10 Cytovance Biologics
    • 13.10.1 Cytovance Biologics Company Details
    • 13.10.2 Cytovance Biologics Business Overview
    • 13.10.3 Cytovance Biologics Biopharmaceutical Contract Manufacturing Introduction
    • 13.10.4 Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
    • 13.10.5 Cytovance Biologics Recent Development
  • 13.11 KBI Biopharma
    • 10.11.1 KBI Biopharma Company Details
    • 10.11.2 KBI Biopharma Business Overview
    • 10.11.3 KBI Biopharma Biopharmaceutical Contract Manufacturing Introduction
    • 10.11.4 KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
    • 10.11.5 KBI Biopharma Recent Development
  • 13.12 WuXi Biologics
    • 10.12.1 WuXi Biologics Company Details
    • 10.12.2 WuXi Biologics Business Overview
    • 10.12.3 WuXi Biologics Biopharmaceutical Contract Manufacturing Introduction
    • 10.12.4 WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
    • 10.12.5 WuXi Biologics Recent Development
  • 13.13 Abzena
    • 10.13.1 Abzena Company Details
    • 10.13.2 Abzena Business Overview
    • 10.13.3 Abzena Biopharmaceutical Contract Manufacturing Introduction
    • 10.13.4 Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
    • 10.13.5 Abzena Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Biopharmaceutical Contract Manufacturing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical Contract Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Lonza Group
    Baxter Biopharma Solutions
    Samsung
    Fujifilm Diosynth Biotechnologies
    Boehringer Ingelheim
    Patheon
    Rentschler Biotechnologie
    Biomeva
    Probiogen
    Cytovance Biologics
    KBI Biopharma
    WuXi Biologics
    Abzena

    Market segment by Type, the product can be split into
    Growth Factors
    Interferons
    Monoclonal Antibodies
    Recombinant Hormones
    Vaccines
    Insulin
    Others
    Market segment by Application, split into
    Autoimmune Diseases
    Oncology
    Metabolic Diseases
    Ophthalmology
    Cardiovascular Diseases
    Infectious Diseases
    Neurology
    Respiratory Disorders
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now